Medicare has established a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 weight-loss drugs between July 1, 2026, and December 31, 2027. The program is called the Medicare GLP-1 Bridge. The Medicare GLP-1 Bridge will be nationwide and available in all states and territories. Only Medicare Part D beneficiaries who are enrolled in eligible plan types, use GLP-1s to reduce excess body weight and maintain weight reduction, and meet the Medicare GLP-1 Bridge Clinical Criteria will be eligible for coverage under the Medicare GLP-1 Bridge. More detailed information for beneficiaries on how to access GLP-1s through the Medicare GLP-1 Bridge will be forthcoming prior to the launch on July 1, 2026.
- The Center for Medicare has produced a quick-guide to the Medicare GLP-1 Bridge – download it here.